A former testing site researcher in Texas has alleged that Pfizer’s pre-licensure BNT162b2 (also known as "Comirnaty") COVID-19 biologic trials included falsification of data, unblinding patients, employing inadequately trained vaccinators, and delays in following up on experimental COVID...